Actually, our recent study has reported that BCOR, a main component of PRC1.1 is frequently mutated in human MBSHHs; its deletion increases Igf2 transcriptional activation via histone H2A modification, causing enhanced tumor progression in SHH-driven murine tumors (Kutscher et al., 2020). This evidence concerns the gene IGF2 and neoplasm.